Rutosid: Bioflavonoid for chronic venous insufficiency and lymphedema
Rutosid (also rutin) is a natural bioflavonoid from the class of flavonol glycosides. It occurs in numerous plants, especially in buckwheat, elderberry, southernwood, capers, cocoa and in the Sophora japonica tree. In pharmaceuticals, primarily standardized extracts from Sophora japonica and semisynthetically produced mixed extracts of hydroxyethyl rutosides (oxerutin) are used. Well-known brand names include Venoruton, Phlebodril and Tropenova.
Rutosid has been established for decades in phytotherapeutic treatment of venous and lymphatic disorders. Clinical studies and reviews have supported its use, particularly in chronic venous insufficiency, posttraumatic edema and lymphedema. Unlike aescin (horse chestnut), rutosid belongs to the less profiled but nevertheless valuable herbal active ingredients that are often prescribed as a supplement to compression therapy.
Mechanism of action
In chronic venous insufficiency, venous pressure rises, capillary permeability increases, plasma proteins and erythrocytes escape into the tissue and cause edema, inflammation and skin trophic disturbances. Rutosid acts at several points in this pathophysiology. It lowers capillary permeability by exerting endothelial stabilization effects and reduces erythrocyte aggregation in postcapillary venules.
Pharmacologically, rutosid is an antioxidant and free radical scavenger. It inhibits pro-inflammatory mediators such as histamine, bradykinin and reactive oxygen species that are elevated in the venous microenvironment. It also improves the rheological properties of blood, which optimizes microcirculation and oxygen supply to the tissue.
The oral bioavailability of free rutosid is low, which is why pharmacy predominantly uses hydroxyethylated derivatives (oxerutin) that are significantly better absorbed. Half-life approximately ten hours, elimination renal after metabolic conjugation.
Indications
- Chronic venous insufficiency stage I to II: heaviness, pain, swelling, cramps, itching
- Posttraumatic and postoperative edema: following injuries, operations, lymph node removal
- Lymphedema: as supplementary therapy to manual lymph drainage and compression therapy
- Hemorrhoids: in case of venous stasis as supportive measure
- Pregnancy-related leg vein complaints: during pregnancy (with medical consultation)
Dosage and administration
Standard dose (oxerutin): Initially 600 to 1,000 mg/day orally divided into two doses over two to three weeks, followed by maintenance therapy with 300 to 500 mg/day. Onset of action: after two to four weeks, significant improvement after eight to twelve weeks.
Topical: Apply gel two to three times daily to the affected area. Local application supplements oral therapy and may be the treatment of choice in patients with gastrointestinal intolerance.
Renal insufficiency and hepatic insufficiency: in moderate to severe functional impairment, halve the dose or evaluate use individually.
Adverse effects
Common: gastrointestinal complaints such as nausea, heartburn, mild diarrhea, especially at the beginning of therapy. Skin rash and itching with topical application.
Occasional: headaches, fatigue, allergic reactions.
Rare: skin rash, anaphylactoid reaction, hepatotoxicity in individual case reports.
Important: Patients with known allergy to bioflavonoids or Sophora japonica should avoid rutosid. In case of unilateral leg swelling with tension pain, warmth and redness, there is suspicion of deep venous thrombosis, which must be clarified medically and cannot be replaced by phytotherapy.
Drug interactions
- Anticoagulants (warfarin, DOAC): theoretical interactions via CYP enzymes or additive antithrombotic effects, clinically poorly documented, INR monitoring advisable with concomitant medication
- Other phytotherapeutics for vein disorders (aescin, diosmin, hesperidin): additive effect possible, in practice usually not prescribed simultaneously
- Iron preparations: rutosid can reduce iron absorption through complex formation, staggered intake recommended
- NSAIDs: long-term combination can increase gastrointestinal irritation
Special precautions
Pregnancy and lactation: Data limited, oral use during pregnancy is assessed with caution, topical application is considered safe. Preferably avoid during lactation. Discuss with physician before starting therapy.
Compression therapy as gold standard: Rutosid supplements compression therapy for chronic venous insufficiency but does not replace it. In stage II and above, medical compression stockings class II are the basis of therapy.
Differential diagnosis: unilateral acute leg swelling may indicate deep venous thrombosis and requires immediate diagnostic clarification.
Duration of therapy: Long-term use over months is possible, regular medical monitoring is advisable to assess efficacy and tolerability and to detect deterioration early.
You may also be interested in
- Aescin, active ingredient from horse chestnut
- Diosmin, another bioflavonoid for venous insufficiency
- Troxerutin, semisynthetic flavonoid derivative
- Oxerutin, hydroxyethylated rutosid mixture
- Heparin, anticoagulant therapy for thrombosis
Frequently asked questions
What is the difference between rutosid and oxerutin?
Rutosid is the original bioflavonoid from plants such as Sophora japonica, buckwheat or elderberry. Oxerutin is a semisynthetically produced hydroxyethylated mixture of several rutosid derivatives with significantly better oral bioavailability. In Germany, oxerutin preparations are typically prescribed.
How long does it take for rutosid to work?
First improvements are often noticeable after two to four weeks, with the full effect developing over eight to twelve weeks. Combining with compression therapy and exercise improves efficacy.
Can I take rutosid during pregnancy?
Topical application is considered safe, oral use should be discussed with your gynecology practice before starting therapy. For venous complaints during pregnancy, compression stockings and exercise are first-line measures.
Do buckwheat tea or similar home remedies help equally?
Buckwheat contains rutosid in small and variable amounts, a therapeutic effect cannot be reliably achieved with tea or foods alone. Standardized phytotherapeutics guarantee a defined active ingredient content and are therefore preferable.
Sources
- Gelbe Liste, rutosid and oxerutin active ingredient profile
- AWMF guidelines chronic venous insufficiency and lymphedema
- BfArM, Federal Institute for Drugs and Medical Devices
- Cochrane Reviews on bioflavonoids in chronic venous disease
Legal notice and disclaimer
The information provided on this page is for general information purposes only and does not constitute medical advice, diagnosis or treatment recommendation. It does not replace the advice of a licensed physician or pharmacist. Medicines should always be taken only on medical prescription or under pharmacy supervision. All information is based on published technical information at the time of preparation and recognized scientific sources, with the current technical information from the manufacturer being authoritative at all times. Sanoliste assumes no liability for completeness, accuracy or correctness of the presented information. In case of a medical emergency, call emergency number 112.